USC Stevens Executes Exclusive Global IP Licensing Agreement with NeOnc Technologies

In honor of Brain Cancer Awareness Month, USC Stevens Center for Innovation is proud to announce that we have executed an exclusive global IP licensing agreement with NeOnc Technologies for an enhanced method of delivering novel pharma therapeutics to the brain. This USC licensing agreement is notably considered the largest IP transfer for the commercialization of chemotherapies related to the brain and other CNS diseases. 

To read the full story, click here.